Challenges in the Understanding of Oligometastatic Disease in Clinical Practice
The term OMD involves certain difficulties in definition and management. Positive and negative trials have further added uncertainty regarding who would best benefit from local treatment. The discordance in outcome expectations from physicians and patients will need to be addressed to ensure that patient's goals of care are met.
Authors
- Aisling Barry (ORCID: https://orcid.org/0000-0003-2734-7090)
- Philip W. Wong (ORCID: https://orcid.org/0000-0002-7761-0283)
- Jane Tsai
- Inmaculada Navarro-Domenech
- Grace Ma (ORCID: https://orcid.org/0000-0001-7186-5202)
Institutions
- University College Cork (IE)
- Hospital Universitario La Paz (ES)
- Princess Margaret Cancer Centre (CA)
- Community Care (US)
Publication Details
- Journal
- Cureus
- Published
- 2024-10-27
- DOI
- https://doi.org/10.7759/cureus.72500
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42